Pioneering Statistical Approaches to Accelerate Drug Development through Adaptive Trial Designs

June 30, 2016

In recent years, experts in the development and regulation of medical products have explored promising new adaptive clinical trial designs to help speed innovative new therapies to patients in need. This white paper, based on a 2014 think tank meeting, outlines the potential role of adaptive designs in streamlining the drug development process and the remaining statistical and methodological challenges that will need to be tackled before the designs can achieve more widespread use.